GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...

A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

Groundbreaking research reveals how common diabetes medications might offer unprecedented protection against heart attacks ...

The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...

A new study examines how cost, side effects and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

A diabetes pill that lowers blood sugar levels can also slash the risk of heart attacks and strokes in older people, a study has found. Experts are now calling for NHS guidance – which does not ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...